In meal replacement, Glanbia announced the sale of Slim Fast at the beginning of 2025
Its buyer beware basically, Wilcox said
The glucagon receptor component is hypothesised, based on preclinical and early clinical data, to increase energy expenditure and promote fat breakdown (lipolysis)
The company has cut more than 450 jobs since March 2025 in an effort to tighten its budget
Highlighting the eight companies with potential to be acquired in the coming months
PubMed Finan, B., Yang, B., Ottaway, N., Smiley, D.L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K.M., Fischer, K., Campbell, J.E., Sandoval, D., Seeley, R.J., Bleicher, K., Uhles, S., Riboulet, W., Funk, J., Hertel, C., Belli, S., Sebokova, E., Conde-Knape, K., Konkar, A., Drucker, D.J., Gelfanov, V., Pfluger, P.T., Mller, T.D., Perez-Tilve, D., DiMarchi, R.D., & Tschp, M.H